Abstract
Numerous studies have demonstrated that the Acetyl Coenzyme A-dependent arylamine NAT enzyme exist in many tissues of experimental animals including humans, and that NAT has been shown to be exist in mouse brain tissue. Increased NAT activity levels are associated with increased sensitivity to the mutagenic effects of arylamine carcinogens. Attenuation of liver NAT activity is related to breast and bladder cancer processes. Therefore, the effects of ellagic acid (EA) on the in vitro and in vivo N-acetylation of 2-aminofluorene (AF) were investigated in cerebrum, cerebellum and pineal gland tissues from male Sprague-Dawley rats. For in vitro examination, cytosols with or without EA (0.5–500 μM) co-treatment decreased 7–72%, 15–63% and 10–78% of AF acetylation for cerebrum, cerebellum and pineal gland tissues, respectively. For in vivo examination, EA and AF at the same time treated groups with all 3 examined tissues did show significant differences (the changes of total amounts of AF and AF metabolites based on the Anova analysis) when compared to the ones without EA cotreatment rats. The pretreatment of male rats with EA (10 mg/kg) 24 hr prior to the administration of AF (50 mg/kg) (one day of EA administration suffice to induce large changes in phase II enzyme activity) resulted in a 76% decrease in total AF and metabolites in pineal gland but did not show significant differences in cerebrum and cerebellum tissues. This is the first demonstration to show that EA decreases the N-acetylation of carcinogens in rat brain tissues.
Similar content being viewed by others
REFERENCES
Klein, G. and Klein, E. 1985. Nature (London) 315:190–195.
Miller, E. C. and Miller, J. A. 1981. Mechanisms of chemical carcinogenesis. Cancer 47:1055–1064.
Later, D. W., Andros, T. C., and Lee, M. L. 1983. Isolation and identification of amino polycyclic aromatic hydrocarcinogens from coal-derived products. Anal. Chem. 55:2126–2132.
Kriek, E. 1979. Aromatic mines and related compounds as carcinogenic hazards to man. In: P. Emmelot and E. Kriek (eds), Environmental carcinogenesis. pp. 143–164. Amsterdam: Elsevier/North-Holland Biomedical Press.
Radomski, J. L. 1979. The primary aromatic amines, their biological properties and structure-activity relationships. Annu. Rev. Pharmacol. Toxicol. 19:129–157.
Morris, H. P. 1955. Hepatocarcinogenesis by 2-acetylaminofluorene and related compounds including comments on dietary and other influences. J. Natl. Cancer Inst. 15:1535–1545.
Rudo, K., Meyer, W. C., Dauterman, W., and Langenbach, R. 1987. Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylaminofluorene. Cancer Res. 47:5861–5867.
Chung, J. G., Levy, G. N., and Weber, W. W. 1993. Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-NatS slow acetylator congenic mice. Drug Metabol. Dispos. 21:1057–1063.
Miller, E. C., Miller, J. A., Sandin, R. B., and Brown, R. K. 1949. The carcinogenic activities of certain analogues of 2-acetylaminofluorene in the rat. Cancer Res. 9:504–509.
Miller, J. A., Sandin, R. B., Miller, E. C., and Rusch, H. P. 1955. The carcinogenicity of compounds related to 2-acetylaminofluorene. II. Variations in the bridges and the 2-substituent. Cancer Res. 42:1317–1321.
Lee, J. H., Hung, C. F., Ho, C. C., Chang, S. H., Lai, Y. S., and Chung, J. G. 1997. Light-induced changes in frog pineal gland N-acetyltransferase activity. Neurochem. Int. 31:533–540.
Aryton, A. D., Lewis, D. F. V., Walker, R., and Ionnides, C. 1992. Antimutagenicity of ellagic acid towards the food mutagen IQ: investigation into possible mechanisms of action. Fd. Chem. Toxicol. 30:289–295.
Stoner, G. D. and Mukhtar, H. 1995. Polyphenols as cancer chemopreventive agents. J. Cell Biochem. 22(Suppl.):169–180.
Tanaka, T., Iwata, H., Niwa, K., Mori, Y., and Mori, H. 1988. Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male AVI/N rats. Jpn. J. Cancer Res. (Gann.). 79:1297–1303.
Das, M., Bickers, D. R., and Mukhtar, H. 1985. Effects of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies of the mechanism of its anticarcinogenic action. Carcinogenesis 6:1409–1413.
Mandal, S. and Stoner, G. D. 1990. Inhibition of of N-nitro-sobenzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis 11:55–61.
Akagi, K., Hirose, M., Hosgiya, T., Mizoguchi, Y., Ito, N., and Shirai, T. 1995. Modulating effects of ellagic acid, vanillin and quercetin in rat medium term multi-organ carcinogenesis model. Cancer Letts. 94:113–121.
Ahn, D., Puto, D., Kresty, L., Stoner, G. D., Fromm, D., and Hollenberg, F. 1996. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzyme. Carcinogenesis 17:821–828
Ho, C. C., Tsai, H. Y., Lai, Y. S., and Chung, J. G. 1999. Effects of the ellagic acid on the N-acetyltransferase activity and acetylation of 2-aminofluorene in the rat. Toxicol. Environ. Chem. 71:319–329.
Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
Svensson, C. K. and Knowlton, P. W. 1989. Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat. Pharmaceutical Res. 6:477–450.
Minchin, R. F., Reeves, P. T., Teitel, C. H., McManus, M. E., Mojarrabi, T., Ilett, K. F., and Kadlubar, F. F. 1992. N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells. Biochem. Biophys. Res. Commun. 185: 839–844.
Grant, D. M., Josephy, P. D., and Lord, H. L. 1992. Salmonella typhimurium strains expressing human arylamine N-acetyltransferase: metabolism and mutagenic activation of aromatic amines. Cancer Res. 52:3961–3964.
Weber, W. W. and Hein, D. W. 1985. N-acetylation pharmacogenetics. Pharmacol. Review. 37:25–79.
Weber, W. W. 1987. The acetylator genes and drug response, Oxford University Press. New York.
Einisto, P., Watanabe, M., Ishidate, M., and Nohmi, T. 1991. Mutagenicity of 30 chemicals in S. Typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutation Res. 259:95–102.
Barch, D. H. and Rundhaugen, L. M. 1992. Hepatology 16:99A.
Barch, D. A., Rundhaugen, L. M., Thomas, P. E., and Kardos, P. 1994. Dietary ellagic acid inhibits the enzymatic activity of CYP1A1 without altering hepatic concentrations of CYP1A1 or CYP1A1 mRNA. Biochem. Biophys. Res. Commun. 201: 1477–1482.
Rocci, M. L., Jr. and Jusko, W. J. 1983. LAGRAN program for area and moments in pharmacokinetic analysis. Comp. Prog. Biomed. 16:203–216.
Zidek, Z., Friebova, M., Janku, I., and Elis, J. 1981. Influence of sex and Freund's adjuvant on liver N-acetyltransferase activity and elimination of sulphadimidine in urine of rats. Biochem. Pharmacol. 26:69–70.
DuSouich, P. and Courteau, H. 1981. Induction of acetylation capacity with complete Freund's adjuvant and hydrocortisone in the rabbit. Drug Metab. Dispos. 9:279–283.
Chung, J. G., Chang, H. L., Yeh, C. C., Lu, H. F., Chang, C. C., and Tsai, H. D. 2000. Effects of the immunodulator tilorone on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rats. Anticancer Res. 20:467–473.
Reeves, P. T., Minchin, R. F., and Ilett, K. F. 1987. Induction of sulfamethazine acetylation by hydrocortisone in the rabbit. Drug Metab. Dispos. 16:110–115.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lin, S.S., Hung, C.F., Ho, C.C. et al. Effects of Ellagic Acid by Oral Administration on N-Acetylation and Metabolism of 2-Aminofluorene in Rat Brain Tissues. Neurochem Res 25, 1503–1508 (2000). https://doi.org/10.1023/A:1007632326953
Issue Date:
DOI: https://doi.org/10.1023/A:1007632326953